In breast cancer patients, the association with nodal status, as well as significant impact upon overall survival, highlights the clinical relevance of SATB1. Small molecules targeting SATB1 may thus be a promising approach in treating breast cancer patients. Here, SATB1 is linked to breast carcinoma.